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Rod vision is initiated when 11-cis-retinal, bound within rhodopsin, absorbs a photon and isomerizes to all-trans-
retinal (ATR). This triggers an enzyme cascade that lowers cGMP, thereby closing cyclic nucleotide-gated (CNG)
channels. ATR then dissociates from rhodopsin, with bright light releasing millimolar levels of ATR. We have
recently shown that ATR is a potent closed-state inhibitor of the rod CNG channel, and that it requires access to
the cytosolic face of the channel (McCabe, S.L., D.M. Pelosi, M. Tetreault, A. Miri, W. Nguitragool, P. Kovithvatha-
naphong, R. Mahajan, and A.L. Zimmerman. 2004. 
 
J
 
. 
 
Gen
 
. 
 
Physiol
 
. 123:521–531). However, the details of the in-
teraction between the channel and ATR have not been resolved. Here, we explore the nature of this interaction
by taking advantage of speciﬁc retinoids and retinoid analogues, namely, 
 
 
 
-ionone, all-trans-C15 aldehyde, all-
trans-C17 aldehyde, all-trans-C22 aldehyde, all-trans-retinol, all-trans-retinoic acid, and all-trans-retinylidene-
 
n
 
-
butylamine. These retinoids differ in polyene chain length, chemical functionality, and charge. Results obtained
from patch clamp and NMR studies have allowed us to better deﬁne the characteristics of the site of retinoid–
channel interaction. We propose that the cytoplasmic face of the channel contains a retinoid binding site. This
binding site likely contains a hydrophobic region that allows the ionone ring and polyene tail to sit in an optimal
position to promote interaction of the terminal functional group with residues 
 
 
 
15 Å away from the ionone ring.
Based on our functional data with retinoids possessing either a positive or a negative charge, we speculate that
these amino acid residues may be polar and/or aromatic.
 
INTRODUCTION
 
Cyclic nucleotide-gated (CNG) channels mediate the
light response in retinal rods and cones. Rod CNG
channels are thought to be tetramers consisting of one
 
 
 
 (CNGB1) and three 
 
 
 
 (CNGA1) subunits (Weitz et al.,
2002; Zheng et al., 2002; Zhong et al., 2003), each with
a cyclic nucleotide binding domain on its cytoplasmic
COOH terminus. Gating of these channels is modulated
by several factors including phosphorylation enzymes
(Gordon et al., 1992; Molokanova et al., 1997), calcium
binding proteins (Matulef and Zagotta, 2003; Trudeau
and Zagotta, 2003), and by retinoids, speciﬁcally all-trans-
retinal (ATR) (Dean et al., 2002; McCabe et al., 2004).
ATR is a member of the retinoid family, a class of
compounds that includes vitamin A and its derivatives
(Nau and Blaner, 1999). These compounds are known
to regulate such physiological processes as gene tran-
scription and immune responses, and play a major role
in visual transduction. During visual transduction in
rods, the chromophore 11-cis-retinal photoisomerizes
to ATR and is then released from its binding pocket in
opsin. A bright light is thought to cause the release of
millimolar levels of ATR (Saari, 1999). Although much
of the ATR is likely buffered by membranes and proteins
within the outer segment, some is expected to be acces-
sible to the CNG channels located in the nearby plasma
membrane.
We have shown that ATR can inhibit cloned rod CNG
channels (Dean et al., 2002; McCabe et al., 2004). This
inhibition is potent, especially at low, near physiological
levels of cGMP, in which case it inhibits in the nanomolar
range. ATR is a closed-state inhibitor that prefers un-
liganded channels and has profound effects on the
channel’s cGMP sensitivity. Previous work also suggests
that ATR requires access to the intracellular surface of
the channel (McCabe et al., 2004), which implies that
inhibition by ATR is not the result of a nonspeciﬁc
bilayer effect. However, it is still unclear whether the
inhibition involves nonspeciﬁc hydrophobic interactions
between ATR and the channel, or whether the channel
contains a speciﬁc retinoid binding site. In this study
we have used retinoid analogues to explore this question
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in more detail. We used retinoid analogues of differing
polyene chain lengths, namely, 
 
 
 
-ionone, and all-trans-
C15, all-trans-C17, and all-trans-C22 aldehydes (see Fig.
1), which have been used by others to explore the
mechanism of opsin activation (Jin et al., 1993; Bu-
czylko et al., 1996; Kefalov et al., 1999; Crouch et al.,
2002). We also have used all-trans-retinoic acid and all-
trans-retinylidene-
 
n
 
-butylamine to investigate the role
of charge in the inhibition. Our results suggest that the
inhibitory effect of retinoids is not merely the result of
nonspeciﬁc hydrophobic interactions with the chan-
nel. Instead, there is likely a binding site with speciﬁc
length and charge requirements necessary for retinoids
to inhibit the rod CNG channel.
 
MATERIALS AND METHODS
 
Expression of Channels in 
 
Xenopus
 
 Oocytes
 
The CNG channel clone for the bovine rod 
 
 
 
 subunit (CNGA1;
GenBank/EMBL/DDBJ accession no. NM-174278) was provided
by W.N. Zagotta (University of Washington, Seattle, WA) (in the
pGEMHE plasmid). The pGEMHE plasmid contains the untrans-
lated sequence of the 
 
Xenopus
 
 
 
 
 
-globin gene to promote high pro-
tein expression in oocytes (Liman et al., 1992). Channel cRNA
was made by in vitro transcription using Ambion’s mMessage
mMachine
 
TM
 
 kit. Partial ovariectomies were performed on anes-
thetized 
 
Xenopus laevis
 
 frogs, and individual oocytes were isolated
by treatment with 
 
 
 
1 mg/ml collagenase type 1A (Sigma-Aldrich)
in a low-calcium solution (82.5 mM NaCl, 2.5 mM KCl, 5 mM
HEPES, 1 mM MgCl
 
2
 
 at pH 7.6) for 
 
 
 
1 h. Channel cRNA was in-
jected into oocytes using a Drummond “NANOJECT” injector.
Typically, 
 
 
 
50 nl of 1 
 
 
 
g/
 
 
 
l CNGA1 cRNA was injected into each
egg. Injected oocytes were incubated at 16
 
 
 
C for 3–12 d before
patch clamp experiments. Oocytes were stored in a solution con-
taining: 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl
 
2
 
, 5 mM HEPES, 1
mM MgCl
 
2,
 
 2.5 mM pyruvic acid, 100 U/ml penicillin, and 100
 
 
 
g/ml streptomycin, at pH 7.6. The vitelline membrane was re-
moved by mechanical dissection after treatment with a hypertonic
solution containing 100 mM 
 
N
 
-methyl-
 
d
 
-glucamine, 2 mM KCl, 10
mM EGTA, 10 mM HEPES, and 1 mM MgCl
 
2
 
, at pH 7.4.
 
Electrophysiological Solutions and their Application
 
All-trans-retinal, all-trans-retinol, all-trans-retinoic acid, and 
 
 
 
-ion-
one were purchased from Sigma-Aldrich. All-trans-C15, all-trans-
C17, and all-trans-C22 aldehydes were produced in Dr. Crouch’s
lab. The synthesis of these retinoids has been described previously
(Buczylko et al., 1996). All-trans-retinylidene-
 
n
 
-butylamine was
produced in Dr. Borhan’s lab following the methods of Govard-
han and Oprian (Govardhan and Oprian, 1994). See Fig. 1 for
the molecular structure of each compound. The cell chamber for
patch clamp experiments was a glass Petri dish. Water soluble so-
lutions were applied using a 36-solution patch perfusion system,
RSC-100 rapid solution changer (Molecular Kinetics). Both sides
of the patches were bathed in a low-divalent sodium solution con-
sisting of 130 mM NaCl, 500 
 
 
 
M EDTA, and 2 mM HEPES, at pH
7.2. The solution bathing the intracellular surface of the patch
contained 2 mM cGMP (Sigma-Aldrich) dissolved in the low-diva-
lent solution. Niﬂumic acid (500 
 
 
 
M; Sigma-Aldrich) was added
to the extracellular solution to block Ca
 
2
 
 
 
-activated Cl
 
 
 
 channels
endogenous to 
 
Xenopus
 
 oocytes. For retinoids stored in benzene,
nitrogen gas was used to evaporate the benzene before prepara-
tion of a retinoid stock in ethanol. All retinoid stocks were made
in 100% ethanol and kept in amber glass vials covered in alumi-
num foil and stored at 
 
 
 
80
 
 
 
C or 
 
 
 
20
 
 
 
C until use. The purity and
stability of the stocks were checked by measuring absorption spec-
tra (200–800 nm) with a Beckman DU640 spectrophotometer. Ret-
inoids were applied to the intracellular surface of patches by re-
moving 
 
 
 
50% of the bath volume, vigorously mixing the retinoid
stock into this solution using a glass Pasteur pipette in a glass bea-
ker, and then pouring this solution back into the remaining bath
and mixing again. We found that the greatest concentration
of ethanol applied to any patch had no effect on cGMP-acti-
vated current or on the seal resistance. Petri dishes and agar
bridges were replaced after each experiment. ATR degradation
was checked spectroscopically under both dim and bright room
light conditions. Under dim room light no degradation was seen;
however, degradation was apparent in brighter room light. Thus,
for all retinoid experiments, dim room light was used. 
 
Electrophysiological Recordings and Analysis
 
Standard patch clamp methods were used to record currents
from excised, inside-out patches. Pipette openings were typically
0.5–5 
 
 
 
m in diameter with resistances of 1.0–15 M
 
 
 
 after ﬁre
polishing. All recordings were obtained at room temperature.
Currents were recorded in response to 200-ms voltage pulses
ranging from 
 
 
 
100 to 
 
 
 
100 mV in 50-mV steps from a holding
potential of 0 mV; or, where indicated, 1.5-s pulses to 
 
 
 
100, 
 
 
 
50,
 
 
 
50, or 
 
 
 
100 mV from a holding potential of 0 mV. Leak cur-
rents were measured in the low divalent solution without cGMP
and were subtracted from each record. All currents were mea-
sured in the steady state after completion of voltage-dependent
gating (Karpen et al., 1988) and before signiﬁcant ion depletion
(Zimmerman et al., 1988). 
Retinoids were added to patches only after allowing for com-
pletion of the spontaneous increases in apparent cGMP afﬁnity
of the rod channel due to dephosphorylation by endogenous
patch-associated phosphatases (Gordon et al., 1992; Molokanova
et al., 1997). This increase in apparent cGMP afﬁnity took tens of
minutes and was monitored by sampling the current periodically
at a cGMP concentration (typically 10 
 
 
 
M) that was below the
K
 
1/2
 
, while incubating the patch the rest of the time in saturating
cGMP (2 mM) to accelerate the process (Molokanova et al.,
1999). 
For retinoid dose–response relations, the bath (i.e., intracellu-
lar surface of the patch) contained a saturating concentration of
cGMP (2 mM). The current was monitored for 
 
 
 
1 h after each
addition of retinoid to ensure that steady state had been reached
(see Fig. S1 for representative time course plots of several retin-
oids used in this study, available at http://www.jgp.org/cgi/content/
full/jgp.200509387/DC1). Typically one or two retinoid concen-
trations were tested per patch. For most patches, the leak was
rechecked at the end of the experiment by applying the low diva-
lent solution to the patch through a glass capillary tube an-
chored in the bath and attached to a syringe.
Patch currents were recorded using an Axopatch 1B or 200
patch clamp ampliﬁer (Axon Instruments, Inc.) with analogue-
to-digital converters connected to a Macintosh Quadra or G4
computer running Pulse software (Instrutech). The data were
low-pass ﬁltered at 2 kHz and sampled at 10 kHz. Data analysis
was performed using the IgorPro software package (WaveMet-
rics). All data points used in the dose–response relations were
measured at 
 
 
 
100 mV in saturating (2 mM) cGMP at the indi-
cated retinoid concentration. All points shown are averages of
several patches. Smooth curves are ﬁts with the Hill equation:
IN/IN
 
max
 
 
 
 
 
 [Ret]
 
n
 
/(IC
 
50
n
 
 
 
 
 
 [Ret]
 
n
 
), where IN 
 
 
 
 percent inhibi-
tion, IN
 
max
 
 
 
 
 
 maximal percent inhibition, IC
 
50
 
 
 
 
 
 concentration
of retinoid required for half maximal inhibition, Ret 
 
 
 
 retinoid
or retinoid analogue, and n is the Hill coefﬁcient. 
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Nuclear Magnetic Resonance
 
Retinoids were examined by NMR in aqueous solution. Initially,
the powdered form of the retinoid was dissolved in DMSO to
make a concentrated stock. Separately, 180 mM DPC solution
(dodecylphosphocholine-
 
d38
 
) was prepared in 20 mM phos-
phate buffer at pH 7.0. The retinoid stock was added to 600 
 
 
 
l
buffer containing micelles to obtain a ﬁnal retinoid concentra-
tion of 2 mM.
All NMR experiments were collected at 298 K on a 600 MHz
Bruker Avance spectrometer. The reported chemical shift values
for 
 
1
 
H were expressed in ppm and referenced to the 
 
1
 
H reso-
nance from TSP at 0.0 ppm. Two-dimensional total correlation
spectroscopy (TOCSY) was performed with a mixing time of 35
ms. The spin lock ﬁeld was 10 kHz. The water signal was sup-
pressed using a WATERGATE sequence. For radical-induced re-
laxation, the 16-doxylstearic acid was solubilized in methanol-
 
d
 
4
 
to a ﬁnal concentration of 60 mM. 5 
 
 
 
l of this solution was added
to the retinoid/DPC solution. TOCSY experiments were re-
corded under identical conditions before and after the addition
of the doxylstearic acid. Intensities of the peaks were measured
before and after addition of the doxylstearic acid (van de Ven et
al., 1993; Pellegrini et al., 1998).
 
Online Supplemental Material
 
Fig. S1 (available at http://www.jgp.org/cgi/content/full/jgp.
200509387/DC1) shows representative time course plots for ATR,
all-trans-retinol (ATRol), and C22 aldehyde applied to inside-out
patches in the presence of saturating (2 mM) cGMP. In each case,
the inhibition reached steady state over the course of 
 
 
 
1 h.
 
RESULTS
 
We have previously shown that ATR can inhibit the rod
CNG channel (Dean et al., 2002; McCabe et al., 2004).
Here, we examine the structural features of ATR re-
sponsible for the inhibition with the long-range aim of
determining the site of interaction of ATR with the
channel. ATR is composed of an ionone ring and a
hydrophobic nine-carbon long chain with conjugated
double bonds ending in an aldehyde group (see Fig.
1). Several retinoids and retinoid analogues were em-
ployed in this study; their structures are shown in Fig. 1.
The ﬁrst structural feature examined was the polyene
chain length. 
 
 
 
-ionone, the compound with the short-
est polyene chain, was unable to inhibit the rod CNG
channel at concentrations as high as 10 
 
 
 
M in saturat-
ing (2 mM) cGMP (Fig. 2 A). This concentration of 
 
 
 
-ion-
one far exceeds the IC
 
50
 
 (220 nM) for inhibition of the
channel by ATR (McCabe et al., 2004). What about
compounds with polyene chain lengths between those
of 
 
 
 
-ionone and ATR? As seen in Fig. 1, C15 and C17 al-
dehydes are four and two carbons shorter than ATR, re-
spectively. As illustrated in Fig. 2 (B and C), C15 and
C17 aldehydes gave little, if any, inhibition of the chan-
nel, even at concentrations (1 
 
 
 
M) much larger than
the IC
 
50
 
 for ATR. Since the critical micellar concentra-
tion of ATRol is reported to be 2 
 
 
 
M (Noy, 1999),
higher concentrations of C15 and C17 aldehyde were
not applied to patches due to the potential formation
of micelles in solution.
We next tested C22 aldehyde, a retinoid with a poly-
ene chain that is two carbons longer than ATR. Fig. 3 A
shows a representative patch where 400 nM C22 alde-
hyde produced 46% inhibition in the presence of satu-
rating (2 mM) cGMP. Fig. 3 B shows a dose–response
relation for this inhibition. Although the IC
 
50
 
 for C22
aldehyde (415 nM) is almost twice that of the IC
 
50
 
 for
ATR, C22 aldehyde can still be considered a potent in-
hibitor. The Hill coefﬁcient for C22 aldehyde (
 
n
 
 
 
  
 
2.5)
predicts a steeper curve than that predicted for ATR
(
 
n
 
 
 
  
 
1.4; McCabe et al., 2004); however, it is not clear
whether this difference is meaningful, since it may re-
ﬂect limitations in our ability to accurately measure this
parameter for such slow, lipophilic inhibitors.
These results imply that there is a critical chain
length necessary for inhibition of the channel. There
are two possible reasons why polyene chain length
might be important in inhibition, the ﬁrst of which
seems more likely: (1) the channel may have a speciﬁc
retinoid binding site that dictates a preferred distance
between the ionone ring and the terminal functional
group; (2) partitioning of retinoids into hydrophobic
regions of the channel may be the determining factor
in their inhibitory ability. In the latter case, shorter ret-
inoids (
 
 
 
-ionone, C15, and C17 aldehyde) would in-
hibit the channel less efﬁciently than longer retinoids
Figure 1. Structures of retinoids and retinoid analogues. All-
trans-retinal (ATR), all-trans-retinol (ATRol),  -ionone, all-trans-
C15 aldehyde, all-trans-retinoic acid (RA), all-trans-retinylidene-n-
butylamine (ATR-NBu), all-trans-C17 aldehyde, and all-trans-C22
aldehyde. (All-trans-C15, C17, and C22 aldehydes are named
based on the total number of carbons, including methyl groups, as
per Buczylko et al., 1996. Though depicted as charged, the actual
charge states of RA and ATR-NBu within the retinoid binding site
are not known.) 
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(ATR and C22 aldehyde), since they would not be ex-
pected to partition as effectively. This hypothesis would
also predict that C22 would be a better inhibitor than
ATR, since its polyene chain is longer by two carbons.
The ﬁnding that C22 is a less effective inhibitor than
ATR suggests that hydrophobic partitioning of retin-
oids is not the main determinant of inhibitor potency.
Additional evidence that ATR likely inhibits via a spe-
ciﬁc binding site within the channel comes from stud-
ies using nuclear magnetic resonance (NMR). The rela-
tive partitioning of ATR and C17 aldehyde was mea-
sured in dodecylphosphocholine (DPC) micelles, using
nitroxide radical–induced relaxation of the 
 
1
 
H NMR
signals of the retinoids following standard procedures
(Pellegrini et al., 1998). Both ATR and C17 aldehyde
were found to readily incorporate into the DPC mi-
celle, based on the increase in NMR line width. Upon
addition of 16-doxylstearic acid to the solution, which
Figure 2.  -Ionone, and C15 and C17 aldehydes do not signiﬁ-
cantly inhibit the homomeric rod CNG channel in the presence of
saturating cGMP. Currents were measured from multichannel,
inside-out patches of homomeric (CNGA1) rod channels at
saturating (2 mM) cGMP. The raw traces represent families of
cGMP-activated currents in response to voltage steps ranging from
 100 to  100 mV in 50-mV increments from a holding potential
of 0 mV. Currents measured in the absence of cGMP were sub-
tracted from all traces. Black traces represent currents before the
addition of the indicated retinoid; red traces represent currents
after 1 h (steady state) in the indicated retinoid. Similar results for
 -ionone, C15, and C17 aldehyde were obtained with 9, 3, and 15
patches, respectively. (A) There was no change in current with 10
 M  -ionone. (B) Currents were reduced by 8% in 1  M C15 alde-
hyde. (C) Currents were reduced by 11.5% in 1  M C17 aldehyde.
Figure 3. C22 aldehyde is a potent inhibitor of the homomeric
rod CNG channel. (A) The raw traces represent families of cGMP-
activated currents in response to voltage steps ranging from  100
to  100 mV in 50-mV increments from a holding potential of 0
mV. Currents measured in the absence of cGMP were subtracted
from all traces. Black traces represent currents in saturating cGMP
before the addition of C22 aldehyde; red traces represent currents
after 1 h (steady state) in 400 nM C22 aldehyde (46% inhibition).
(B) The dose–response relation for C22 aldehyde inhibition of the
rod CNG channel. All points were measured at  100 mV after 1 h
(steady state) in the indicated concentration of C22 aldehyde and
saturating (2 mM) cGMP. Data were normalized to maximal
current in 2 mM cGMP in the absence of C22 aldehyde, with leak
current in the absence of cGMP subtracted from each trace. Each
point is an average from two to three patches, and the smooth
curve is a ﬁt with the Hill equation, where the IC50   415 nM, and
n   2.5.Horrigan et al. 457
places the nitroxide radical approximately in the core
of the micelle (van de Ven et al., 1993), the NMR sig-
nals for both ATR and C17 aldehyde are diminished,
indicating close proximity to the electron radical. The
1H signals for the ATR are reduced by  56% on aver-
age upon the addition of the 16-doxylstearic acid; the
radical-induced relaxation for C17 aldehyde is similar
or even greater for some protons. These results indi-
cate that although C17 aldehyde is shorter, its partition-
ing into the zwitterionic micelles of DPC is similar to
that of ATR. Therefore, the ability of ATR to inhibit the
channel potently, while C17 aldehyde demonstrates no
inhibition, is likely due to a speciﬁc channel–retinoid
interaction and is not solely determined by hydropho-
bic partitioning.
Considering our results with C22 aldehyde and the
NMR data, it seems likely that retinoids interact with
the channel via a speciﬁc binding site. To test whether
the terminal functional group affects this interaction,
we ﬁrst compared inhibition by ATRol with that by ATR
(see Fig. 1 for structures). Fig. 4 A shows a representa-
tive family of traces in response to 400 nM ATRol, and
Fig. 4 B shows the dose–response relation for ATRol in-
hibition. Based on the IC50 values of ATR and ATRol
(220 and 300 nM respectively), it seems that ATR may
be only slightly more potent than ATRol.
We next examined retinoid analogues with terminal
functional groups that may carry a negative (all-trans-
retinoic acid [RA]) or a positive (all-trans-retinylidene-
n-butylamine [ATR-NBu]) charge (see DISCUSSION).
Fig. 5 A shows that 400 nM RA did not inhibit the chan-
nel. If the site contains aromatic and/or polar residues,
then ATR-NBu should be a very effective inhibitor. Fig.
5 B (top) shows a representative family of traces in
which 80 nM ATR-NBu conferred 60% inhibition in
the presence of saturating (2 mM) cGMP. ATR-NBu was
a much more potent inhibitor than any other retinoid
tested (see Table I). These results suggest that the retin-
oid binding site prefers a positively charged over a neg-
atively charged functional group. It is possible that
ATR-NBu is acting as a slow voltage-dependent blocker
like dequalinium (Rosenbaum et al., 2003, 2004), at a
site distinct from the retinoid binding site. However,
this does not seem to be the case. Fig. 5 B (bottom)
shows a representative set of traces from the same
patch as that shown in the top panel, in which each
voltage pulse was applied for 1.5 s in the presence of 80
nM ATR-NBu and 2 mM cGMP after steady state was
reached. There is no slow increase in current at nega-
tive voltages, or decrease in current at positive voltages
characteristic of voltage-dependent blockers like de-
qualinium (Rosenbaum et al., 2004). Thus, ATR-NBu
does not appear to be a slow voltage-dependent blocker,
but instead most likely inhibits via the same mechanism
as the other retinoids tested.
DISCUSSION
We have shown that a hydrophobic polyene chain
length of at least nine carbons is essential for retinoid
inhibition of the rod CNG channel. Retinoids with
shorter chains, speciﬁcally  -ionone, and C15 and C17
aldehydes, are not able to signiﬁcantly inhibit the chan-
nel. In contrast, ATR, C22 aldehyde, and ATRol, all
with longer polyene chains, are potent inhibitors. We
have provided two lines of evidence suggesting that hy-
Figure 4. ATRol is a potent inhibitor of the homomeric rod CNG
channel. (A) The raw traces represent families of cGMP-activated
currents in response to voltage steps ranging from  100 to  100
mV in 50-mV increments from a holding potential of 0 mV.
Currents measured in the absence of cGMP were subtracted from
all traces. Black traces represent currents in saturating cGMP (2
mM) before the addition of ATRol; red traces represent currents
after 1 h (steady state) in 400 nM ATRol (63% inhibition). (B)
The dose–response relation for ATRol inhibition of the rod CNG
channel. All points were measured at  100 mV after 1 h (steady
state) in the indicated concentration of ATRol and saturating (2
mM) cGMP. Data were normalized to maximal current in 2 mM
cGMP in the absence of ATRol, with leak current in the absence of
cGMP subtracted from each. Each point is an average from two to
four patches, and the smooth curve is a ﬁt with the Hill equation,
where the IC50   300 nM, and n   1.4.458 Defining the CNG Channel Retinoid Binding Site
drophobic partitioning alone is not the active mecha-
nism for retinoid inhibition of the rod CNG channel.
First, C22 aldehyde is a slightly less potent inhibitor
than ATR (see Table I); and second, NMR studies indi-
cate that ATR and C17 aldehyde partition similarly into
DPC micelles. These results suggest a speciﬁc interac-
tion between the retinoid and the channel, likely via a
retinoid binding site. Although we cannot rule out the
possibility that retinoids inhibit by binding to an inter-
mediary protein, this possibility seems unlikely since we
have measured quantitatively similar retinoid inhibi-
tion of CNG channels in patches pulled from rod outer
segments (unpublished data).
The analogues examined here allow for some deﬁni-
tion of the putative retinoid binding site. The length of
the polyene chain, measured from carbon 4 (located at
the side of the ionone ring farthest from the aldehyde
group) to the oxygen bound to carbon 15 (see Fig. 1),
provides valuable insight into the requirements for
channel inhibition. Table I presents an estimate of this
length for each analogue. The retinoids with lengths
that are  15 Å ( -ionone, and C15 and C17 aldehydes)
do not inhibit, whereas C22 aldehyde (17.5 Å distance)
does inhibit, but not as well as ATR, ATRol, or ATR-
NBu (each with a 15-Å distance). This suggests that the
binding site prefers retinoids with a terminal functional
group  15 Å removed from carbon 4.
Taken together, these data suggest that the channel
has a retinoid binding site that likely contains two re-
gions that are a preferred distance (15 Å) apart. One
region constrains the ionone ring while holding the hy-
drophobic tail in an optimal position for interaction of
the terminal functional group with residues located at
the second region 15 Å away. As the distance between the
ionone ring and the terminal functional group increases
or decreases (i.e., if the hydrocarbon tail is shortened
or lengthened), this interaction is diminished and the
inhibition reduced or ablated. However, we do not yet
know whether the ionone ring structure per se is re-
quired for inhibition, since a series of retinoids lacking
the ionone ring have not yet been tested.
We have also shown that the identity of the functional
group located at the end of the polyene chain is very im-
Figure 5. RA does not inhibit the homomeric rod CNG channel;
ATR-NBu does inhibit, but not in a voltage-dependent way.
Currents were measured from multichannel, inside-out patches of
homomeric (CNGA1) rod channels at saturating (2 mM) cGMP.
The raw traces in A and B (top) represent families of cGMP-
activated currents in response to voltage steps ranging from  100
to  100 mV in 50-mV increments from a holding potential of 0
mV. Currents measured in the absence of cGMP were subtracted
from all traces. The traces in B (bottom) represent cGMP-activated
currents in response to longer (1.5 s) voltage pulses to  100,  50,
 50, or  100 mV from 0 mV after inhibition in 80 nM ATR-NBu
reached steady state. The dashed line represents the baseline
(i.e., zero current). The holding potential was 0 mV during the
application of ATR-NBu. Black traces represent currents in saturat-
ing cGMP prior to the addition of RA or ATR-NBu; red or blue
traces represent currents after 1 h in RA or ATR-NBu, respectively.
(A) 400 nM RA gave no inhibition (red); similar results were seen
in two other patches. (B, top) 80 nM ATR-NBu conferred 60%
inhibition (blue); (bottom) 1.5-s voltage pulses on the same patch
as in the top panel after 1 h in 80 nM ATR-NBu do not show any
voltage dependence of ATR-NBu inhibition.
TABLE I
Chain Length and Inhibitory Potency of Retinoid Analogues
Retinoid
Distance from carbon 4 
to carbon 15 (Å) Inhibitory potency
 -ionone 7.55 No inhibition
C15 aldehyde 10.06 No inhibition
C17 aldehyde 12.58 No inhibition
C22 aldehyde 17.5 IC50   415 nM
ATRa 15 IC50   220 nM
ATRol 15 IC50   300 nM
RA ( ) 15 No inhibition
ATR-NBu ( )b 15 IC50    80 nM
aIC50 from McCabe et al. (2004).
bDistance from C4 to C15 is 15 Å, but butylamine chain extends past the
functional group (Fig. 1).Horrigan et al. 459
portant in the inhibition, and therefore can speculate
about the nature of the residues within the channel that
may be involved in the inhibition. Since ATRol is ap-
proximately as potent an inhibitor as ATR, it seems un-
likely that formation of a Schiff base within the binding
site is the active mechanism for inhibition. Our results
with RA and ATR-NBu provide evidence that the bind-
ing site likely contains polar and/or aromatic amino
acid residues. However, further experiments are re-
quired to test this hypothesis, since the charge states of
ATR-NBu and RA within the binding site are not known.
Finally, our results with ATR-NBu suggest that the bind-
ing site is not sterically limited immediately after the sec-
ond interaction site; the structure of ATR-NBu extends
several carbons beyond the 15-Å point (at which its func-
tional group is located), and yet it is a potent inhibitor.
Since we have previously shown that ATR requires ac-
cess to the intracellular side of the channel in order to
confer inhibition (McCabe et al., 2004), it seems plausi-
ble that the retinoid binding site is located on the intra-
cellular side of the channel, such as in the cytosolic NH2
or COOH terminus. Alternatively, the site could lie be-
tween neighboring subunits, or in other regions that
are associated with the membrane surface and are ac-
cessible only from the intracellular side. Since ATR-
NBu, and previously ATR (McCabe et al., 2004), showed
no voltage dependence, it is unlikely that the retinoid
binding site lies within the membrane electric ﬁeld. The
identity of the amino acids within this retinoid interac-
tion site and their exact location within the channel
structure remain to be determined. However, it seems
reasonable to propose that the retinoid binding site is
hydrophobic and has two key regions of interaction: the
ﬁrst of which constrains the ionone ring and hydrocar-
bon tail, while the second site is 15 Å removed from this
site and interacts with the terminal functional group via
polar and/or aromatic residues. This interaction with
the terminal functional group is essential for inhibition.
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